Search for content, post, videos

NextCell granted patent protection in Japan

NextCell Pharma has announced that the Japan Patent Office (JPO) has issued a notice of allowance relating to the patent entitled "Allogeneic Composition". The patent describes the method of manufacturing the drug candidate ProTrans, where the selection algorithm is key for selecting optimal cell
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.